A severe case of hidradenitis suppurativa with chronic anemia treated with adalimumab

Abstract

findings suggest that the anemia symptoms improved secondary to the improvement of the underlying inflammation. Since adalimumab is expected to have therapeutic effects not only on skin symptoms but also on complications in patients with HS, we recommend an indepth study of more cases in the future.